Total Visits

Views
A european multicentre and open-label controlled randomized trial to evaluate the efficacy of sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: The STARMEN study135

Total Visits Per Month

November 2023December 2023January 2024February 2024March 2024April 2024May 2024
A european multicentre and open-label controlled randomized trial to evaluate the efficacy of sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: The STARMEN study3101630

File Visits

Views
european_rojas_CKJ_2015.pdf100

Top country views

Views
United States44
China15
Ireland10
Denmark9
Russia9
France6
Saudi Arabia6
Spain5
Vietnam5
Germany4

Top cities views

Views
Ashburn18
Dublin10
Hanoi5
Riyadh5
Boardman3
Shanghai3
Bengaluru2
Brno2
Frankfurt am Main2
Helsinki2